Lincocin: Potent Gram-Positive Bacterial Infection Treatment
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $7.55 | $75.45 (0%) | 🛒 Add to cart |
| 20 | $7.04 | $150.91 $140.85 (7%) | 🛒 Add to cart |
| 30 | $6.34 | $226.36 $190.14 (16%) | 🛒 Add to cart |
| 60 | $4.43 | $452.73 $265.60 (41%) | 🛒 Add to cart |
| 90 | $4.23 | $679.09 $380.29 (44%) | 🛒 Add to cart |
| 120 | $4.02 | $905.45 $482.91 (47%) | 🛒 Add to cart |
| 180 | $3.72 | $1358.18 $670.03 (51%) | 🛒 Add to cart |
| 270 | $3.42 | $2037.26 $923.56 (55%) | 🛒 Add to cart |
| 360 | $3.02
Best per pill | $2716.35 $1086.54 (60%) | 🛒 Add to cart |
Synonyms | |||
Lincocin, known generically as lincomycin, is a lincosamide antibiotic prescribed for the treatment of serious infections caused by susceptible strains of gram-positive bacteria. It is particularly valued in clinical settings where penicillin is not suitable or where anaerobic organisms are involved. This injectable solution offers a targeted mechanism of action, inhibiting bacterial protein synthesis to effectively halt the progression of severe infections. Its use is reserved for situations demanding potent antimicrobial intervention under strict medical supervision.
Features
- Active ingredient: Lincomycin hydrochloride
- Available as a sterile solution for intramuscular or intravenous injection
- Each mL contains lincomycin hydrochloride equivalent to 300 mg lincomycin
- Mechanism: Inhibits bacterial protein synthesis at the ribosomal level
- Spectrum: Primarily effective against gram-positive aerobes and anaerobes
- Presentation: Supplied in vials and syringes for precise dosing
Benefits
- Provides rapid bactericidal activity against susceptible strains, crucial for severe infections.
- Effective alternative for patients with hypersensitivity to penicillin or beta-lactam antibiotics.
- Demonstrates reliable tissue penetration, including bone, making it suitable for osteomyelitis.
- Offers a focused spectrum, potentially reducing the risk of disrupting normal gut flora compared to broad-spectrum agents.
- Can be administered via IV for systemic coverage or IM for sustained release in appropriate cases.
- Trusted in hospital settings for its consistent pharmacokinetic profile and predictable efficacy.
Common use
Lincocin is indicated for the treatment of serious infections caused by susceptible strains of streptococci, pneumococci, and staphylococci. It is commonly employed in cases of septicemia, lower respiratory tract infections, and skin and soft tissue infections. Its utility extends to bone and joint infections, including osteomyelitis, due to its effective bone penetration. It is also used in situations where the infection involves anaerobic bacteria, such as in intra-abdominal abscesses or pelvic inflammatory disease. Use is typically reserved for moderate to severe infections where less potent antibiotics are inadequate or contraindicated.
Dosage and direction
Dosage must be individualized based on the severity of the infection and the patient’s clinical status. For serious infections in adults, the usual dose is 600 mg intramuscularly every 12 to 24 hours, or 600 mg to 1 g intravenously every 8 to 12 hours. For more severe infections, intravenous administration of up to 8 grams per day has been used. For children over one month of age, the recommended dosage is 10 to 20 mg/kg/day intramuscularly in divided doses, or 10 to 20 mg/kg/day intravenously in divided doses. Intravenous administration should be by slow infusion, diluted in not less than 100 mL of compatible solution, and infused over at least one hour. Rapid IV administration must be avoided to minimize cardiovascular side effects.
Precautions
Lincocin should be used with caution in patients with a history of gastrointestinal disease, particularly colitis. Antibiotic-associated colitis, including pseudomembranous colitis, has been reported with nearly all antibacterial agents and may range in severity from mild to life-threatening. Therefore, it is essential to consider this diagnosis in patients who present with diarrhea during or subsequent to the administration of Lincocin. Use with caution in patients with severe renal or hepatic impairment; dosage adjustments may be necessary. Monitor renal and hepatic function periodically during prolonged therapy. As with many antibiotics, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi.
Contraindications
Lincocin is contraindicated in patients with known hypersensitivity to lincomycin, clindamycin, or any component of the formulation. It should not be used in patients with a history of antibiotic-associated colitis, enteritis, or regional enteritis. Use is also contraindicated in the treatment of minor bacterial or viral infections, such as uncomplicated upper respiratory tract infections. Not for intrathecal administration. Avoid in neonates due to immature organ system function.
Possible side effect
Common side effects include nausea, vomiting, abdominal pain or cramping, and diarrhea. Skin rash and itching may occur. Pain, induration, and sterile abscess at the injection site have been reported with intramuscular injection. Thrombophlebitis may occur with intravenous administration. More serious side effects include severe colitis, which may present as persistent diarrhea, abdominal cramping, and fever; leukopenia, neutropenia, agranulocytosis, and thrombocytopenia have been observed. Hypersensitivity reactions, including anaphylaxis, angioedema, and serum sickness-like reactions, although rare, have been reported. Hepatic dysfunction, including jaundice and abnormalities in liver function tests, has been noted.
Drug interaction
Lincocin has neuromuscular blocking properties and may enhance the action of other neuromuscular blocking agents; concomitant use with such drugs should be approached with caution. Antagonism has been demonstrated between Lincocin and erythromycin in vitro; therefore, concomitant use is not recommended. Kaolin-pectin may reduce the absorption of orally administered lincomycin; this formulation is less common. It may potentiate the effects of warfarin, requiring closer monitoring of prothrombin time.
Missed dose
If a dose is missed, it should be administered as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended. Maintaining consistent serum levels is important for efficacy, so adherence to the prescribed schedule is advised. Consult the prescribing healthcare provider for specific guidance based on the clinical context.
Overdose
Symptoms of overdose may include severe nausea, vomiting, and diarrhea. Neuromuscular blockade, leading to muscle weakness or paralysis, and profound hypotension may occur, particularly with rapid intravenous administration. There is no specific antidote for lincomycin overdose. Treatment is supportive and symptomatic. Hemodialysis or peritoneal dialysis is not effective in removing lincomycin from the blood. Maintain airway patency and provide assisted ventilation if neuromuscular blockade occurs. Monitor and support blood pressure and renal function.
Storage
Store at controlled room temperature, 20° to 25°C (68° to 77°F). Protect from light. The solution should be clear; discard if discolored or if particulate matter is present. After dilution for intravenous infusion, the solution is stable for 24 hours at room temperature. Do not freeze. Keep out of reach of children and pets. Dispose of unused medication appropriately according to local regulations.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay in seeking it because of something you have read here. The efficacy and safety profile discussed are based on typical use and may not apply to all individuals.
Reviews
“Lincocin proved effective in a challenging case of methicillin-sensitive staphylococcal osteomyelitis where previous beta-lactams failed. The IV administration was well-tolerated, with careful monitoring for GI side effects.” – Infectious Disease Specialist, 12 years of experience.
“While potent, it requires vigilant monitoring for colitis. In our hospital, it’s a go-to for anaerobic coverage in abdominal infections, but we always ensure appropriate susceptibility testing first.” – Clinical Pharmacist.
“Used it in a patient with penicillin allergy presenting with severe pneumonia. Saw marked improvement within 72 hours. The need for slow IV infusion is crucial to avoid adverse effects.” – Pulmonologist.